Publication & Citation Trends
Publications
0 total
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma OA
Cited by 24
Semantic Scholar
In-Depth Characterization and Validation in BRG1-Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI/SNF Chromatin Remodeling OA
Cited by 8
Semantic Scholar
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
Cited by 187
Semantic Scholar
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers OA
Cited by 367
Semantic Scholar
Abstract 444: BRM/SMARCA2 is a critical synthetic lethal target in BRG1-deficient cancers
Cited by 0
Semantic Scholar
Research Topics
Chromatin Remodeling and Cancer
(14)
Cancer Mechanisms and Therapy
(13)
Mechanisms of cancer metastasis
(10)
PI3K/AKT/mTOR signaling in cancer
(7)
Melanoma and MAPK Pathways
(7)
Affiliations
Novartis (Switzerland)
American Institutes for Research
Boston Biomedical Research Institute
Novartis (China)
Novartis (United States)